BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 26687081)

  • 1. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.
    Zhang G; Zhang Y
    Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of induced pluripotent stem cells.
    Okita K; Nagata N; Yamanaka S
    Circ Res; 2011 Sep; 109(7):720-1. PubMed ID: 21921270
    [No Abstract]   [Full Text] [Related]  

  • 3. Generation of Viable Mice from Induced Pluripotent Stem Cells (iPSCs) Through Tetraploid Complementation.
    Kang L; Gao S
    Methods Mol Biol; 2015; 1330():125-32. PubMed ID: 26621595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regenerative cells for transplantation in hepatic failure.
    Ishikawa T; Banas A; Teratani T; Iwaguro H; Ochiya T
    Cell Transplant; 2012; 21(2-3):387-99. PubMed ID: 22793046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of pluripotent stem cells and their derivatives.
    de Almeida PE; Ransohoff JD; Nahid A; Wu JC
    Circ Res; 2013 Feb; 112(3):549-61. PubMed ID: 23371903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem Cell Therapy and Immunological Rejection in Animal Models.
    Jin X; Lin T; Xu Y
    Curr Mol Pharmacol; 2016; 9(4):284-288. PubMed ID: 26415913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will SCNT-ESCs be better than iPSCs for personalized regenerative medicine?
    Sancho-Martinez I; Izpisua Belmonte JC
    Cell Stem Cell; 2013 Aug; 13(2):141-2. PubMed ID: 23910080
    [No Abstract]   [Full Text] [Related]  

  • 8. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
    Pellegrini S; Piemonti L; Sordi V
    Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induced pluripotent stem cells: youthful indiscretions].
    Qiang B; Hamamah S; De Vos J
    Med Sci (Paris); 2011 Oct; 27(10):805-7. PubMed ID: 22027413
    [No Abstract]   [Full Text] [Related]  

  • 10. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and allogenicity: a challenge of stem cell therapy.
    Charron D; Suberbielle-Boissel C; Al-Daccak R
    J Cardiovasc Transl Res; 2009 Mar; 2(1):130-8. PubMed ID: 20559977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetraploid complementation proves pluripotency of induced pluripotent stem cells derived from adipose tissue.
    Zhou C; Cai X; Fu Y; Wei X; Fu N; Xie J; Lin Y
    Cell Prolif; 2015 Feb; 48(1):39-46. PubMed ID: 25430589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction to human stem cell transplants with extension to their differentiated progeny.
    Lui KO; Howie D; Ng SW; Liu S; Chien KR; Waldmann H
    Nat Commun; 2014 Dec; 5():5629. PubMed ID: 25434740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of embryonic stem cells and their progeny.
    Drukker M
    Methods Enzymol; 2006; 420():391-409. PubMed ID: 17161708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.